Ann: Acrux and Eli Lilly to appeal patent ruling on Axiron-ACR.AX, page-29

I.m.o.
as below.....

1) Of course ACR/Eli Lilly can market its own generic Axiron. But.....why.....the only advantage which the generic products are prices. If Eli Lilly can accept its profit margin to be 50% lower, it can still possibly own 90% of the market share;

2) ? No idea what does the question mean?

3) The idea seems to suggest Coles to lose 50% of its supermarket sale in Sydney and Melbourne but try to boost its sale in Darwin and Canberra.

4) ACR will still receive royalties in spite of could be much less. To suggest ACR to wind up is like to suggest a shop owner to close his/her shop if their profit(not loss) down 50%!